While many pandemic emergent companies grapple with cautious consumerism and stale demand, CleanSpace (ASX: CSX), a respiratory technology company, breathes a sigh of relief with their 30% sales growth as compared to last year. 

In April 2024, they launched CleanSpace WORK, their lightest powered respirator, and at a lesser price point. Their new target audience is small businesses, tradespeople, and workers facing respiratory risks, offering the same top-tier protection (99.97%) but at a more accessible price point.  Sales figures continued to soar in H2 with a 33% increase which is an unaudited figure, and will have clearer insight in August 2024. 

Compared to traditional PAPRs, CleanSpace WORK is much lighter with increased comfort which is needed for workers to move around frequently. With a more affordable price, WORK can also be used by multiple individuals by following disinfection procedures. This can substantially reduce costs for small businesses, specially where individual PAPR’s aren’t feasible due to high costs but are essential to work.

A strategic shift in CleanSpace’s market focus, in FY24, 97% of the company’s revenue stemmed from industrial sectors, marking a significant change from their previous emphasis on healthcare markets during the pandemic. During the pandemic’s surge in demand for respiratory protection, CleanSpace’s IPO may have thrived, but this initial success didn’t guarantee a steady prosperity. Post pandemic, many ASX entrants like Cleanspace have faced financial difficulties after relying heavily on pandemic-driven sales.  

Companies that ramped up production to meet peak demands left with excess inventory, leading to potential product obsolescence, were left with no choice but to sell it at lower costs. All of these factors combined created havoc for pandemic driven companies in the post-pandemic landscape.

In the immediate aftermath of Covid, Post-pandemic, Cleanspace’s revenue slumped, prompting cost-cutting measures like staff layoffs. However, their strategic partnership with Capstone Health Alliance in the US and introduction of new products such as Bluetooth-enabled lines aided their counteract. 

For the first Half Year ended 31 December 2023, CleanSpace reported revenue of $7.3 million which represented a 27% increase on the previous corresponding period. However, the company reported an accumulated loss of $14.1 million compared to $12.2 million at the beginning of the period. This results in $2.1 million negative operating cash flow over the same period a year ago. 

As of 31 December 2023, the Company had $10.1 million of cash on hand.